Neurological Disorders and Covid-19 At the University Hospital of Lome

Introduction: In sub-Saharan Africa, data on the association between COVID-19 and neurological conditions are non-existent. We conducted a hospital study whose objective is to describe the possible peculiarities of neurological disorders with recent COVID-19. Method: The study was carried out in the Neurology Department of the CHU Campus de Lomé FROM JANUARY 1 TO December 31, 2021. Patients hospitalized for a neurological condition with a positive COVID-19 PCR test were included. Results: A total of 135 COVID-19 PCR tests were performed. Twenty-seven COVID-19-positive patients were enrolled with an average age of 59 years and a sex ratio of 1. The main antecedents were high blood pressure (69%, n=18), type 2 diabetes (31%, n=8) and stroke (15%, n=4). Reasons for admission were dominated by focused motor deficit (46%, n=12), altered consciousness (27%, n=7), seizures (12%, n=3). The suspicious symptoms of COVID-19 that led to the completion of COVID-19 testing were dominated by asthenia and fever. On extra neurological physical examination, 54% of patients (n=14) had pulmonary condensation syndrome. The most common neurological conditions were stroke. The death rate was 45%. Conclusion: COVID-19 is life-threatening for patients hospitalized for neurological conditions. The issue of long COVID-19 justifies the continuation of studies that characterize Neuro COVID-19.